Antimicrobial agent
|
E. coli
|
Enterobacter spp.
|
Klebsiella spp.
|
Citrobacter spp.*
|
Proteus spp*
|
Acinetobacter spp*
|
---|
(n = 57)
|
(n = 23)
|
(n = 18)
|
(n = 3)
|
(n = 2)
|
(n = 2)
|
---|
ESBL-producing (%) phenotype
|
98.2
|
100.0
|
100.0
|
100.0
|
100.0
|
0
|
Amikacin (%)
|
57.9
|
30.4
|
22.2
|
33.3
|
100.0
|
0
|
Amoxycillin (%)
|
100.0
|
100.0
|
100.0
|
100.0
|
100.0
|
100.0
|
Ampicillin (%)
|
100.0
|
100.0
|
100.0
|
100.0
|
100.0
|
100.0
|
Amoxicillin/clavulanic acid (%)
|
84.2
|
87.0
|
100.0
|
66.7
|
100.0
|
0
|
Ceftazidime (%)
|
100.0
|
100.0
|
100.0
|
100.0
|
100.0
|
100.0
|
Ceftriaxone (%)
|
98.2
|
100.0
|
100.0
|
100.0
|
100.0
|
100.0
|
Cefuroxine (%)
|
98.2
|
100.0
|
100.0
|
100.0
|
100.0
|
100.0
|
Ciprofloxacine (%)
|
96.5
|
82.6
|
83.3
|
100.0
|
100.0
|
100.0
|
Imipenem (%)
|
0
|
4.3
|
0
|
0
|
0
|
0
|
Nitrofurantoin (%)
|
21.1
|
30.4
|
16.7
|
0
|
0
|
0
|
Sulfamethoxazole/trimethopim (%)
|
96.5
|
100.0
|
100.0
|
100.0
|
100.0
|
100.0
|
- *Caution regarding antibiotic-resistance rates, given the low number of isolates assayed.